BI-5756 Reduces Graft-Versus-Host Disease Through CB1-Mediated Treg Upregulation
Gabrielle’s Angel Foundation grantee Jaebok Choi recently published a paper in Molecules. This study tested a new experimental drug called BI-5756 in laboratory and mouse models of bone marrow transplantation. The researchers found that BI-5756 helps calm harmful immune reactions by increasing the number of “regulatory” immune cells that act as natural brakes on inflammation, […]
Read more

